ClinicalTrials.Veeva

Menu

Vacuumtherapy After Venous Hybrid Procedures

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status and phase

Unknown
Phase 4

Conditions

Wound Infection

Treatments

Device: Prevena, KCI, Acelity, NPWT

Study type

Interventional

Funder types

Other

Identifiers

NCT02905955
NL56603.068.16

Details and patient eligibility

About

All patients with deep venous obstruction below the sapheno-femoral junction elective for hybrid procedure with creation of an arterio venous-fistula (AVF) in the MUMC or patients with primary percutaneous procedure (and thus venous obstruction above the sapheno-femoral junction) who present with occluded stents which need an additional AVF after thrombolysis will receive a Prevena NPWT. Incidence of wound infections and wound scoring will be performed afterwards.

Enrollment

40 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with deep venous obstruction below the sapheno-femoral junction primary elective for hybrid procedure with creation of an AV-fistula in the MUMC
  • Be able to communicate in Dutch
  • Life expectancy >1 year

Exclusion criteria

  • Patients with allergies for the components of the used negative pressure incision management system (Prevena)

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Prevena
Other group
Treatment:
Device: Prevena, KCI, Acelity, NPWT

Trial contacts and locations

1

Loading...

Central trial contact

Timme van Vuuren, MD; J. van Laanen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems